Accelerated atherosclerosis in rheumatoid arthritis

Area of Science:

• Rheumatology
• Cardiology
• Immunology

Background:

• Cardiovascular disease is a primary cause of mortality in rheumatoid arthritis (RA).
• Endothelial dysfunction and atherosclerosis are key contributors to cardiovascular risk in RA patients.
• Both traditional risk factors and inflammation-specific mechanisms drive vascular disease in RA.

Purpose of the Study:

• To investigate the role of endothelial dysfunction and atherosclerosis in RA.
• To identify key imaging and laboratory markers for early detection of vascular disease in RA.
• To explore strategies for minimizing cardiovascular risk in RA patients.

Main Methods:

• Assessment of common carotid intima-media thickness (ccIMT) and flow-mediated vasodilation (FMD).
• Evaluation of immunological markers such as anti-CCP antibodies and pro-inflammatory cytokines (TNF-alpha, IL-6).
• Analysis of metabolic markers including homocysteine, dyslipidemia, folate, vitamin B12, and paraoxonase activity.

Main Results:

• RA patients exhibit increased ccIMT and impaired FMD, indicating endothelial dysfunction and atherosclerosis.
• Various immunological and metabolic factors are implicated in the development of vascular disease in RA.
• Early diagnostic markers and therapeutic interventions are crucial for managing cardiovascular risk.

Conclusions:

• Early detection of endothelial dysfunction and atherosclerosis in RA is feasible using imaging and laboratory markers.
• Comprehensive management strategies, including immunosuppressive therapy and lifestyle changes, are essential.
• Close monitoring of RA patients can significantly reduce their cardiovascular risk.